Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 9 - Drugs for disorders of the cardiovascular system
Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
09/2005
09/15/2005US20050202474 Phosphodiesterases
09/15/2005US20050202452 Assay determining the activity of an agent to decrease cell division; contacting protein capable of superoxide production with compound of interest and and measuring the ability of the agent to decrease superoxide production, inhibit diaphorase activity or bind the protein
09/15/2005US20050202394 Organ arrest, protection, preservation and recovery
09/15/2005US20050202110 Composition comprising an aqueous extract of red vine leaves and a blood circulation-improving agent
09/15/2005US20050202101 Method and composition for preventing or reducing the symptoms of insulin resistance syndrome
09/15/2005US20050202083 Storage stable tablets of fosinopril sodium
09/15/2005US20050202061 Optimized dosing for drug coated stents
09/15/2005US20050202048 Chlamydia antigens and vaccine uses of the protein
09/15/2005US20050202008 Promotion or inhibition of angiogenesis and cardiovascularization by tumor necrosis factor ligand/receptor homologs
09/15/2005US20050202007 Determining a P-selectin activity in a biological sample of the subject,increased P-selectin activity in the sample indicates a procoagulant state in the subject
09/15/2005US20050201984 An adenoviral genome replaced with a therapeutic gene or DNA sequence regulated by a ubiquitous promoter either a Cytomegalo virus promotor or a tissue-specific phosphoenolpyruvate carboxykinase promoter, where gene or sequence encodes for a latent human metalloprotease gene MMP-8 (collengenases)
09/15/2005US20050201977 Amino-terminally truncated MCP-2 as chemokine antagonists
09/15/2005US20050201973 Therapeutic supramolecules
09/15/2005CA2812132A1 Natural igm antibodies and inhibitors thereof
09/15/2005CA2559110A1 Endothelial progenitor cells and methods of use thereof
09/15/2005CA2558278A1 Diaryl-substituted five-membered heterocycle derivative
09/15/2005CA2558274A1 Cycloalkanopyridine derivative
09/15/2005CA2557989A1 Sulfated oligosaccharide derivatives
09/15/2005CA2557766A1 Nitrogenous fused-ring derivatives, medicinal compositions containing the derivatives, and use thereof as drugs
09/15/2005CA2557758A1 Medicinal composition for prevention or treatment of overactive bladder accompanying nervous disorder
09/15/2005CA2557320A1 Fused heterocyclic derivatives for prevention or treatment of hyperglycemia
09/15/2005CA2557285A1 Adenosine receptor agonists
09/15/2005CA2557270A1 Pyrrole-derivatives as factor xa inhibitors
09/15/2005CA2557263A1 Kv1.5-blocker for the selective increase of atrial contractility and treatment of cardiac insufficiency
09/15/2005CA2557262A1 Medicament for preventing and/or treating ischemic cardiovascular disease
09/15/2005CA2555712A1 Novel cyclic compound having 4-pyridylalkylthio group having substituted or unsubstituted amino group introduced therein
09/14/2005EP1574518A2 Venom-derived vascular endothelial growth factor-like protein having binding activity specific to vascular endothelial growth factor receptor type 2 and use thereof
09/14/2005EP1574504A1 Benzomorpholine derivatives
09/14/2005EP1574219A2 Method of inhibiting fibrosis with a somatostatin agonist
09/14/2005EP1574214A1 Pharmaceutical composition comprising fenofibrate and process for its preparation
09/14/2005EP1573045A2 Heart failure gene determination and therapeutic screening
09/14/2005EP1573025A2 Crystallized structure of type iv collagen nc1 domain hexamer
09/14/2005EP1572995A2 Novel proteins and nucleic acids encoding same
09/14/2005EP1572930A2 Albumin-fused kunitz domain peptides
09/14/2005EP1572892A2 Human glucagon-like-peptide-1 mimics and their use in the treatment of diabetes and related conditions
09/14/2005EP1572890A2 Slc7s as modifies of the p53 pathway and methods of use
09/14/2005EP1572887A2 Neural regeneration peptide and methods for their use in treatment of brain damage
09/14/2005EP1572881A2 Tacis and br3 polypeptides and uses thereof
09/14/2005EP1572877A2 Drug metabolizing enzymes
09/14/2005EP1572872A2 Igs as modifiers of the p53 pathway and methods of use
09/14/2005EP1572867A2 Endothelial cell expression patterns
09/14/2005EP1572863A2 Method for identifying inhibitors of g protein coupled receptor signaling
09/14/2005EP1572725A1 Novel chi-conotoxin peptides (-i)
09/14/2005EP1572719A2 Partial peptide mimetics and methods
09/14/2005EP1572679A2 Crfr1 selective ligands
09/14/2005EP1572655A2 Novel arylheteroalkylamine derivatives
09/14/2005EP1572628A1 Isophtalic acid derivatives
09/14/2005EP1572246A2 Novel compositions of magnetic particles covered with gem-bisphosphonate derivatives
09/14/2005EP1572211A1 Therapeutic applications of 2-substituted 4-heteroarylpyrimidines
09/14/2005EP1572208A2 Method for counteracting a pathologic change in the beta-adrenergic pathway
09/14/2005EP1572193A1 Microtubule stabilisers for treating stenosis in stents
09/14/2005EP1572189A1 Method of lowering crp and reducing systemic inflammation
09/14/2005EP1572185A1 Lipoxygenase inhibitors as hypolipidemic and anti-hypertensive agents
09/14/2005EP1572183A1 Alpha-2-delta ligand for the treatment of sexual dysfunction
09/14/2005EP1572179A1 Pharmaceutical composition comprising a ltb4 antagonist and a cox-2 inhibitor or a combined cox1/2 inhibitor
09/14/2005EP1572172A1 Alpha2delta ligands for different pharmaceutical uses
09/14/2005EP1572168A2 Anti-infarction molecules
09/14/2005EP1572165A1 New film coating
09/14/2005EP1572126A2 Compositions and methods for altering glucose production
09/14/2005EP1572078A2 NOVEL CURCUMINOID-FACTOR VIIa CONSTRUCTS AS SUPPRESSORS OF TUMOR GROWTH AND ANGIOGENESIS
09/14/2005EP1572071A2 Systems and methods for treating patients with processed lipoaspirate cells
09/14/2005EP1572066A2 Novel method and composition for inhibition of angiogenesis and tumor growth using compounds based on a sequence within mmp-2
09/14/2005EP1572064A2 Pharmaceutical compositions comprising modified cns-derived peptides for promoting nerve regeneration and prevention of nerve degeneration
09/14/2005EP1529048A4 Methods for the synthesis of substituted purines
09/14/2005EP1438060A4 Prevention and treatment of restenosis by local administration of drug
09/14/2005EP1401432B1 Imidazole derivatives for modulating sodium channels
09/14/2005EP1363651B1 Herbal compositions useful as chemopreventive and therapeutic agents
09/14/2005EP1284958B1 Method of inhibiting amyloid protein aggregation and imaging amyloid deposits using aminoidane derivatives
09/14/2005EP1283825B1 N-substituted peptidyl nitriles as cysteine cathepsin inhibitors
09/14/2005EP1258250B1 Nerve protective drugs
09/14/2005EP1250317B1 Bis-basic compounds for use as tryptase inhibitors, method for producing the same and their use as medicaments
09/14/2005EP1210335B1 Aminocarbonyl-substituted benzimidazole derivatives, method for producing same and the use thereof as medicaments
09/14/2005EP1200402B1 Substituted 1,5-dihydropyrrol-2-on derivatives as nmda receptor antagonists for the treatment of pain
09/14/2005EP1091737B1 Use of 1-(3,3-diphenylpropionyl)-4-benzhydril piperazine in the treatment of pain
09/14/2005EP0981343B1 Monoesters of probucol for the treatment of cardiovascular and inflammatory disease
09/14/2005CN1668763A 1L1RL-1 as a cardiovascular disease marker and therapeutic target
09/14/2005CN1668758A Light emitting microorganisms and cells for diagnosis and therapy of diseases associated with wounded or inflamed tissue
09/14/2005CN1668755A Galactosyl isomalt, method for production and use thereof
09/14/2005CN1668728A A process for decreasing environmental pollutants in an oil or a fat, a volatile environmental pollutants decreasing working fluid, a health supplement, and an animal feed product
09/14/2005CN1668644A Selected antibodies and duramycin peptides binding to anionic phospholipids and aminophospholipids and their use in treating viral infections and cancer
09/14/2005CN1668629A Modulation of the expression of genes dependent on STAT-1
09/14/2005CN1668628A Novel thiophene glycoside derivatives, processes for the preparation, medicaments comprising these compounds, and the use thereof
09/14/2005CN1668619A Imidazo[1, 2-a]pyrazin-8-ylamines, method of making and method of use thereof
09/14/2005CN1668615A Novel benzimidazole derivatives
09/14/2005CN1668614A Bicyclic piperidine derivatives as antagonists of the CCR1 chemokine receptor
09/14/2005CN1668611A 1-[(indol-3-yl)carbonyl] piperazine derivatives
09/14/2005CN1668606A Oxazole derivatives and their use as insulin sensitizers
09/14/2005CN1668592A Piperidine derivatives and their use as selective inhibitors of MIP-1alpha binding to its receptor CCR1
09/14/2005CN1668589A Indoline derivatives substituted in the 6 position, their preparation and their use as medicaments
09/14/2005CN1668588A Indole derivatives, method for preparing same and pharmaceutical compositions containing same
09/14/2005CN1668579A Benzamide or phenylacetamide derivatives useful as thyroid receptor ligands
09/14/2005CN1668576A Tetrafluorobenzyl derivatives and pharmaceutical composition for preventing and treating acute and chronic neurodegenerative diseases in central nervous system containing the same
09/14/2005CN1668575A Tgents and methods for the treatment of disorders associated with oxidative stress
09/14/2005CN1668565A Substituted 1, 3-diphenylprop-2-en-1-one derivatives and preparation and uses thereof
09/14/2005CN1668561A Remedy
09/14/2005CN1668337A Agents for gene therapeutic for cerebrovascular disorders
09/14/2005CN1668332A Liquid formulations with a high concentration of human growth hormone (HGH) comprising glycine
09/14/2005CN1668326A Intratumorally administered lactoferrin in the treatment of malignant neoplasms and other hyperproliferative diseases
09/14/2005CN1668325A Lactoferrin in the treatment of malignant neoplasms and other hyperproliferative diseases
09/14/2005CN1668322A Cardioprotective therapies based on enzymatic elimination of lipid peroxides by allene oxide synthase
1 ... 756 757 758 759 760 761 762 763 764 765 766 767 768 769 770 771 772 773 774 775 776 ... 1595